Six out of ten of the world's best-selling drugs are based on molecules called monoclonal antibodies. But their high impact comes with a low profile. This is a story of how basic science quietly became blockbuster medicine. Originally aired 14/08/13.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av Nature Podcast
Visa alla avsnitt av Nature PodcastNature Podcast med Springer Nature Limited finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
